Inhibiting NF-κB activation by small molecules as a therapeutic strategy. - Abstract - Europe PMC
NF-κB - Wikipedia
Nuclear factor kappa B activation appears weaker in schizophrenia patients with high brain cytokines than in non-schizophrenic controls with high brain cytokines | Journal of Neuroinflammation | Full Text
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy
Nuclear Factor κB Signaling in Atherogenesis | Arteriosclerosis, Thrombosis, and Vascular Biology
Cells | Free Full-Text | Challenges with Methods for Detecting and Studying the Transcription Factor Nuclear Factor Kappa B (NF-κB) in the Central Nervous System
Noncanonical NF-κB Signaling Pathway in Liver Diseases
Inhibitors of NF-κB signaling: 785 and counting | Oncogene
IJMS | Free Full-Text | Role of NF-κB in Platelet Function
NF-κB: blending metabolism, immunity, and inflammation: Trends in Immunology
NFκB (Nuclear Factor κ-Light-Chain Enhancer of Activated B Cells) Activity Regulates Cell-Type–Specific and Context-Specific Susceptibility to Calcification in the Aortic Valve | Arteriosclerosis, Thrombosis, and Vascular Biology
Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis? - ScienceDirect